Annual Total Liabilities
$329.38 M
+$30.05 M+10.04%
December 31, 2023
Summary
- As of February 21, 2025, XERS annual total liabilities is $329.38 million, with the most recent change of +$30.05 million (+10.04%) on December 31, 2023.
- During the last 3 years, XERS annual total liabilities has risen by +$203.99 million (+162.69%).
- XERS annual total liabilities is now at all-time high.
Performance
XERS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$349.43 M
-$1.59 M-0.45%
September 30, 2024
Summary
- As of February 21, 2025, XERS quarterly total liabilities is $349.43 million, with the most recent change of -$1.59 million (-0.45%) on September 30, 2024.
- Over the past year, XERS quarterly total liabilities has increased by +$25.51 million (+7.87%).
- XERS quarterly total liabilities is now -0.45% below its all-time high of $351.02 million, reached on June 30, 2024.
Performance
XERS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
XERS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.0% | +7.9% |
| 3 y3 years | +162.7% | +7.9% |
| 5 y5 years | +638.2% | +7.9% |
XERS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.5% | -0.5% | +67.1% |
| 5 y | 5-year | at high | +248.4% | -0.5% | +290.9% |
| alltime | all time | at high | +638.2% | -0.5% | +1116.9% |
Xeris Biopharma Holdings Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $349.43 M(-0.5%) |
| Jun 2024 | - | $351.02 M(+1.5%) |
| Mar 2024 | - | $345.79 M(+5.0%) |
| Dec 2023 | $329.38 M(+10.0%) | $329.38 M(+1.7%) |
| Sep 2023 | - | $323.92 M(+2.8%) |
| Jun 2023 | - | $315.14 M(+8.2%) |
| Mar 2023 | - | $291.31 M(-2.7%) |
| Dec 2022 | $299.33 M(+43.1%) | $299.33 M(+20.7%) |
| Sep 2022 | - | $247.98 M(+1.4%) |
| Jun 2022 | - | $244.67 M(+1.5%) |
| Mar 2022 | - | $241.17 M(+15.3%) |
| Dec 2021 | $209.13 M | $209.13 M(+56.4%) |
| Sep 2021 | - | $133.72 M(+1.6%) |
| Jun 2021 | - | $131.61 M(+6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $123.25 M(-1.7%) |
| Dec 2020 | $125.39 M(+32.6%) | $125.39 M(-19.6%) |
| Sep 2020 | - | $156.05 M(+10.3%) |
| Jun 2020 | - | $141.43 M(+58.2%) |
| Mar 2020 | - | $89.39 M(-5.5%) |
| Dec 2019 | $94.55 M(+111.9%) | $94.55 M(+12.0%) |
| Sep 2019 | - | $84.44 M(+42.9%) |
| Jun 2019 | - | $59.10 M(+9.7%) |
| Mar 2019 | - | $53.87 M(+20.7%) |
| Dec 2018 | $44.62 M(-56.6%) | $44.62 M(+5.1%) |
| Sep 2018 | - | $42.47 M(+46.9%) |
| Jun 2018 | - | $28.92 M(+0.7%) |
| Mar 2018 | - | $28.71 M(-72.1%) |
| Dec 2017 | $102.83 M(+57.1%) | $102.83 M |
| Dec 2016 | $65.47 M | - |
FAQ
- What is Xeris Biopharma Holdings annual total liabilities?
- What is the all time high annual total liabilities for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual total liabilities year-on-year change?
- What is Xeris Biopharma Holdings quarterly total liabilities?
- What is the all time high quarterly total liabilities for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly total liabilities year-on-year change?
What is Xeris Biopharma Holdings annual total liabilities?
The current annual total liabilities of XERS is $329.38 M
What is the all time high annual total liabilities for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual total liabilities is $329.38 M
What is Xeris Biopharma Holdings annual total liabilities year-on-year change?
Over the past year, XERS annual total liabilities has changed by +$30.05 M (+10.04%)
What is Xeris Biopharma Holdings quarterly total liabilities?
The current quarterly total liabilities of XERS is $349.43 M
What is the all time high quarterly total liabilities for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly total liabilities is $351.02 M
What is Xeris Biopharma Holdings quarterly total liabilities year-on-year change?
Over the past year, XERS quarterly total liabilities has changed by +$25.51 M (+7.87%)